Impaired coronary microvascular function and its association with disease duration and inflammation in patients with psoriasis

Echocardiography

Volumn 30, Issue 8, 2013, Pages 912-918

  Gullu, Hakan ^a   Caliskan, Mustafa ^a   Dursun, Recep ^a   Ciftci, Ozgur ^a   Guven, Aytekin ^a   Muderrisoglu, Haldun ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

coronary flow reserve; echocardiography; psoriasis

Indexed keywords

C REACTIVE PROTEIN; DIPYRIDAMOLE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR INFLAMMATION; CHRONIC DISEASE; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; CORONARY FLOW RESERVE; DIASTOLIC BLOOD PRESSURE; DISEASE ACTIVITY; DISEASE DURATION; ECHOCARDIOGRAPH; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HUMAN; HYPEREMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS VULGARIS; SYSTOLIC BLOOD PRESSURE; TISSUE DOPPLER IMAGING;

CORONARY FLOW RESERVE; ECHOCARDIOGRAPHY; PSORIASIS;

ADULT; CAUSALITY; COMORBIDITY; CORONARY ARTERY DISEASE; FEMALE; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; INFLAMMATION; MALE; MICROVESSELS; PREVALENCE; PSORIASIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; TURKEY;

EID: 84883743550     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/echo.12156     Document Type: Article

References (27)

1. Ahlehoff O, Gislason GH, Charlot M, et al. Psoriasis is associated with clinically significant cardiovascular risk: A Danish nationwide cohort study. J Intern Med 2011; 270: 147-157.
2. Gelfand JM, Feldman SR, Stern RS, et al. Determinants of quality of life in patients with Psoriasisoriasis: A study from the US population. J Am Acad Dermatol 2004; 51: 704-708.
3. Gelfand JM, Troxel AB, Lewis JD, et al. The risk of mortality in patients with Psoriasisoriasis: Results from a population-based study. Arch Dermatol 2007; 143: 1493-1499.
4. Wong K, Gladman DD, Husted J, et al. Mortality studies in psoriatic arthritis: Results from a single outpatient clinic. Causes and risk of death. Arthritis Rheum 1997; 40: 1868-1872.
5. Gelfand JM, Neimann AL, Shin DB, et al. Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296: 1735-1741.
6. Britten MB, Zeiher AM, Schachinger V,: Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome. Coron Artery Dis 2004; 15: 259-264.
7. Caiati C, Zedda N, Montaldo C, et al. Contrastenhanced transthoracic second harmonic echo Doppler with adenosine: A noninvasive, rapid and effective method for coronary flow reserve assessment. J Am Coll Cardiol 1999; 34: 122-130.
8. Saraste M, Koskenvuo J, Knuuti J, et al. Coronary flow reserve: Measurement with transthoracic Doppler echocardiography is reproducible and comparable with positron emission tomography. Clin Physiol 2001; 21: 114-122.
9. Fredriksson T, Pettersson U,: Severe Psoriasis-oral therapy with a new retinoid. Dermatologica 1978; 157: 238-244.
10. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009; 10: 165-193.
11. Gullu H, Erdogan D, Caliskan M, et al. Interrelationship between noninvasive predictors of atherosclerosis: Transthoracic coronary flow reserve, flow-mediated dilation, carotid intima-media thickness, aortic stiffness, aortic distensibility, elastic modulus, and brachial artery diameter. Echocardiography 2006; 23: 835-842.
12. Voci P, Pizzuto F, Mariano E, et al. Measurement of coronary flow reserve in the anterior and posterior descending coronary arteries by transthoracic Doppler ultrasound. Am J Cardiol 2002; 90: 988-991.
13. Koshy SK, Govindarajan G,: Rationale and pitfalls of noninvasive coronary flow reserve estimation in assessment of microvascular disease. Echocardiography 2012; 29: 631-633.
14. Caiati C, Montaldo C, Zedda N, et al. Validation of a new noninvasive method (contrast-enhanced transthoracic second harmonic echo Doppler) for the evaluation of coronary flow reserve: Comparison with intracoronary Doppler flow wire. J Am Coll Cardiol 1999; 34: 1193-1200.
15. Hozumi T, Yoshida K, Ogata Y, et al. Noninvasive assessment of significant left anterior descending coronary artery stenosis by coronary flow velocity reserve with transthoracic color Doppler echocardiography. Circulation 1998; 97: 1557-1562.
16. Balci DD, Balci A, Karazincir S, et al. Increased carotid artery intima-media thickness and impaired endothelial function in Psoriasis. J Eur Acad Dermatol Venereol 2009; 23: 1-6.
17. Yiu KH, Yeung CK, Chan HT, et al. Increased arterial stiffness in patients with psoriasis is associated with active systemic inflammation. Br J Dermatol 2011; 164: 514-520.
18. Wikstrom J, Gronros J, Bergstrom G, et al. Functional and morphologic imaging of coronary atherosclerosis in living mice using high-resolution color Doppler echocardiography and ultrasound biomicroscopy. J Am Coll Cardiol 2005; 46: 720-727.
19. De Bruyne B, Hersbach F, Pijls NH, et al. Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but "Normal" coronary angiography. Circulation 2001; 104: 2401-2406.
20. Cortigiani L, Rigo F, Gherardi S, et al. Implication of the continuous prognostic spectrum of Doppler echocardiographic derived coronary flow reserve on left anterior descending artery. Am J Cardiol 2010; 105: 158-162.
21. Wang L, Jerosch-Herold M, Jacobs DR Jr, et al. Coronary risk factors and myocardial perfusion in asymptomatic adults: The multi-ethnic study of atherosclerosis (MESA). J Am Coll Cardiol 2006; 47: 565-572.
22. Shang Q, Tam LS, Yip GW, et al. High prevalence of subclinical left ventricular dysfunction in patients with psoriatic arthritis. J Rheumatol 2011; 38: 1363-1370.
23. Boehncke S, Thaci D, Beschmann H, et al. Psoriasis patients show signs of insulin resistance. Br J Dermatol 2007; 157: 1249-1251.
24. Osto E, Piaserico S, Maddalozzo A, et al. Impaired coronary flow reserve in young patients affected by severe Psoriasis. Atherosclerosis 2012; 221: 113-117.
25. Atzeni F, Sarzi-Puttini P, Sitia S, et al. Coronary flow reserve and asymmetric dimethylarginine levels: New measurements for identifying subclinical atherosclerosis in patients with psoriatic arthritis. J Rheumatol 2011; 38: 1661-1664.
26. Saricaoglu H, Güllülü S, Bülbül Baskan E, et al. Echocardiographic findings in subjects with psoriatic arthropathy. J Eur Acad Dermatol Venereol 2003; 17: 414-417.
27. Galderisi M, Cicala S, Caso P, et al. Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension. Am J Cardiol 2002; 90: 860-864.